Verisante Technology (VRSEF) Stock Price, News & Analysis

Company Overview

Verisante Technology Inc. does not have significant operations. Previously, it was involved in the design and manufacture of cancer diagnostic devices. The company was formerly known as T-Ray Science Inc. and changed its name to Verisante Technology Inc. in January 2011. The company was incorporated in 2006 and is based in Vancouver, Canada.

Key Stats

• Today's Range: $0.0050 to $0.0050
• 50-Day Range: $0.0050 to $0.0050
• 52-Week Range: $0.0023 to $0.01
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: $219,690.00
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

VRSEF Stock Analysis - Frequently Asked Questions

How have VRSEF shares performed this year?

Verisante Technology's stock was trading at $0.0050 on January 1st, 2025. Since then, VRSEF shares have increased by 0.0% and is now trading at $0.0050.
View the best growth stocks for 2025 here.

When did Verisante Technology's stock split?

Shares of Verisante Technology reverse split before market open on Thursday, June 23rd 2022. The 1-10 reverse split was announced on Thursday, June 23rd 2022. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, June 23rd 2022. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

How do I buy shares of Verisante Technology?

Shares of VRSEF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 1/30/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:VRSEF
• CUSIP: N/A
• CIK: N/A
• Web: www.verisante.com
• Phone: (604) 716-5133
• Fax: 604-605-0508
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-70,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -3,741.21%
• Return on Assets: -510.28%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.04
• Quick Ratio: 1.04

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 43,940,000
• Free Float: N/A
• Market Cap: $219,700.00
• Optionable: Not Optionable
• Beta: 19.30